Oppenheimer Asset Management’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.08M | Buy |
30,259
+6,151
| +26% | +$418K | 0.02% | 584 |
|
|
2026
Q1 | $1.81M | Buy |
24,108
+6,518
| +37% | +$534K | 0.02% | 580 |
|
|
2025
Q4 | $1.37M | Sell |
17,590
-3,514
| -17% | -$285K | 0.02% | 598 |
|
|
2025
Q3 | $1.79M | Sell |
21,104
-1,228
| -5% | -$98.4K | 0.02% | 594 |
|
|
2025
Q2 | $1.75M | Sell |
22,332
-3,256
| -13% | -$240K | 0.02% | 600 |
|
|
2025
Q1 | $1.85M | Buy |
25,588
+3,464
| +16% | +$291K | 0.02% | 542 |
|
|
2024
Q4 | $1.96M | Sell |
22,124
-3,016
| -12% | -$269K | 0.02% | 543 |
|
|
2024
Q3 | $2.13M | Buy |
25,140
+3,166
| +14% | +$281K | 0.03% | 526 |
|
|
2024
Q2 | $2.03M | Buy |
21,974
+3,536
| +19% | +$358K | 0.03% | 518 |
|
|
2024
Q1 | $2.08M | Buy |
18,438
+3,340
| +22% | +$333K | 0.03% | 471 |
|
|
2023
Q4 | $1.41M | Sell |
15,098
-3,983
| -21% | -$351K | 0.02% | 609 |
|
|
2023
Q3 | $1.75M | Buy |
19,081
+316
| +2% | +$33.9K | 0.03% | 539 |
|
|
2023
Q2 | $2.28M | Buy |
18,765
+12,230
| +187% | +$1.32M | 0.03% | 465 |
|
|
2023
Q1 | $640K | Buy |
6,535
+35
| +0.5% | +$3.34K | 0.01% | 785 |
|
|
2022
Q4 | $527K | Sell |
6,500
-633
| -9% | -$53.1K | 0.01% | 841 |
|
|
2022
Q3 | $543K | Sell |
7,133
-1,139
| -14% | -$110K | 0.01% | 814 |
|
|
2022
Q2 | $903K | Buy |
8,272
+4,795
| +138% | +$509K | 0.02% | 703 |
|
|
2022
Q1 | $346K | Sell |
3,477
-31
| -0.9% | -$2.96K | ﹤0.01% | 999 |
|
|
2021
Q4 | $336K | Sell |
3,508
-51
| -1% | -$5.11K | ﹤0.01% | 1053 |
|
|
2021
Q3 | $394K | Buy |
3,559
+13
| +0.4% | +$1.48K | 0.01% | 991 |
|
|
2021
Q2 | $410K | Sell |
3,546
-161
| -4% | -$18.5K | 0.01% | 1000 |
|
|
2021
Q1 | $386K | Sell |
3,707
-4,271
| -54% | -$531K | 0.01% | 978 |
|
|
2020
Q4 | $959K | Sell |
7,978
-4,030
| -34% | -$407K | 0.02% | 691 |
|
|
2020
Q3 | $1.04M | Sell |
12,008
-1,060
| -8% | -$91.2K | 0.02% | 606 |
|
|
2020
Q2 | $1.06M | Buy |
13,068
+841
| +7% | +$61.3K | 0.02% | 582 |
|
|
2020
Q1 | $844K | Buy |
12,227
+3,134
| +34% | +$330K | 0.02% | 606 |
|
|
2019
Q4 | $1.04M | Buy |
9,093
+1,054
| +13% | +$131K | 0.02% | 612 |
|
|
2019
Q3 | $1.05M | Buy |
8,039
+162
| +2% | +$21.1K | 0.02% | 593 |
|
|
2019
Q2 | $966K | Buy |
7,877
+731
| +10% | +$84K | 0.02% | 625 |
|
|
2019
Q1 | $751K | Buy |
7,146
+1,085
| +18% | +$117K | 0.02% | 686 |
|
|
2018
Q4 | $621K | Buy |
6,061
+191
| +3% | +$21.2K | 0.02% | 693 |
|
|
2018
Q3 | $697K | Buy |
5,870
+554
| +10% | +$62.6K | 0.02% | 718 |
|
|
2018
Q2 | $510K | Buy |
5,316
+1,780
| +50% | +$165K | 0.01% | 789 |
|
|
2018
Q1 | $287K | Buy |
+3,536
| New | +$274K | 0.01% | 946 |
|
|
2017
Q4 | – | Sell |
-3,193
| Closed | -$196K | – | 1475 |
|
|
2017
Q3 | $196K | Buy |
3,193
+17
| +0.5% | +$1.04K | 0.01% | 1052 |
|
|
2017
Q2 | $192K | Sell |
3,176
-219
| -6% | -$14K | 0.01% | 1046 |
|
|
2017
Q1 | $221K | Buy |
+3,395
| New | +$241K | 0.01% | 1025 |
|
Other funds holding USPH
BG
CCM
SAM
Oppenheimer Asset Management's USPH Position: Q2 2026 in Review
Oppenheimer Asset Management increased its US Physical Therapy (USPH) stake by 26% in Q2 2026, buying an estimated $418K and bringing the position to 30,259 shares worth $2.08M. The position accounts for 0.02% of the portfolio, ranked #584.
Oppenheimer Asset Management first reported a position in USPH in Q1 2017 and has held it in 37 quarters since. The position peaked at $2.28M in Q2 2023. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.
- Oppenheimer Asset Management held 30,259 shares of US Physical Therapy worth $2.08M as of Q2 2026.
- Oppenheimer Asset Management bought 6,151 US Physical Therapy shares in Q2 2026, an estimated $418K.
- US Physical Therapy made up 0.02% of Oppenheimer Asset Management's portfolio in Q2 2026, its #584 holding.
- Oppenheimer Asset Management first reported a position in US Physical Therapy in Q1 2017 and has held it in 37 quarters since.
- Oppenheimer Asset Management's US Physical Therapy position peaked at $2.28M in Q2 2023.
- 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.
Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.